These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33332360)

  • 1. Pre-test probability for SARS-Cov-2-related infection score: The PARIS score.
    Tordjman M; Mekki A; Mali RD; Saab I; Chassagnon G; Guillo E; Burns R; Eshagh D; Beaune S; Madelin G; Bessis S; Feydy A; Mihoubi F; Doumenc B; Mouthon L; Carlier RY; Drapé JL; Revel MP
    PLoS One; 2020; 15(12):e0243342. PubMed ID: 33332360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
    Pardo Lledias J; Ayarza L; González-García P; Salmón González Z; Calvo Montes J; Gozalo Marguello M; Hernández Hernández JL; Olmos Martínez JM
    Rev Esp Quimioter; 2020 Dec; 33(6):410-414. PubMed ID: 32935535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients.
    Gueuning C; Ameye L; Loizidou A; Grigoriu B; Meert AP
    Support Care Cancer; 2022 Sep; 30(9):7635-7643. PubMed ID: 35678883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of coronavirus disease 2019 (COVID-19) pre-test probability on positive predictive value of high cycle threshold severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcription polymerase chain reaction (RT-PCR) test results.
    Gubbay JB; Rilkoff H; Kristjanson HL; Forbes JD; Murti M; Eshaghi A; Broukhanski G; Corbeil A; Fittipaldi N; Hopkins JP; Kristjanson E; Kus JV; Macdonald L; Majury A; Mallo GV; Mazzulli T; Melano RG; Olsha R; Perusini SJ; Tran V; Allen VG; Patel SN
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1179-1183. PubMed ID: 34369325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
    Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
    Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study.
    O'Neill B; Kalia S; Gill P; Hum S; Moran-Venegas C; Stoller R; Greiver M; Agarwal P; Kirubarajan A; DeKoven S; Eisen D; Pinto A; Dunn S
    CMAJ Open; 2021; 9(4):E1134-E1140. PubMed ID: 34876415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing.
    Kurstjens S; van der Horst A; Herpers R; Geerits MWL; Kluiters-de Hingh YCM; Göttgens EL; Blaauw MJT; Thelen MHM; Elisen MGLM; Kusters R
    Clin Chem Lab Med; 2020 Aug; 58(9):1587-1593. PubMed ID: 32598302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of six nucleic acid amplification kits for SARS-CoV-2 RNA detection.
    Wu S; Shi X; Chen Q; Jiang Y; Zuo L; Wang L; Jiang M; Lin Y; Fang S; Peng B; Wu W; Liu H; Zhang R; Kwan PSL; Hu Q
    Ann Clin Microbiol Antimicrob; 2021 May; 20(1):38. PubMed ID: 34022903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Antigen Test LumiraDx
    Cattelan AM; Sasset L; Zabeo F; Ferrari A; Rossi L; Mazzitelli M; Cocchio S; Baldo V
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
    Desai KT; Alfaro K; Mendoza L; Faron M; Mesich B; Maza M; Dominguez R; Valenzuela A; Acosta CD; Martínez M; Felix JC; Masch R; Smith JS; Gabrilovich S; Wu T; Plump M; Novetsky AP; Einstein MH; Douglas NC; Cremer M; Wentzensen N
    Microbiol Spectr; 2021 Oct; 9(2):e0084621. PubMed ID: 34668736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.